Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Address:
SUITE 201, 697 BURKE ROAD CAMBERWELL; MELBOURNE, VICTORIA 3124, AU
LOW
spending power
